
Vivi - Biologics (Opc) Private Limited
Founded in 2020 and headquartered in Andhra Pradesh, India.
Founded in 2020 and headquartered in Andhra Pradesh, India.
Vivi - Biologics (Opc) Private Limited (VBOPL) is a Company incorporated in India on 19 November 2020 (Four years and three months 23 days old ). Its registered office is in Kurnool, Andhra Pradesh, India.
The Company is engaged in the Research & Development Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Telugu Narasaraju serves as a director at the Company.
Kurnool, Andhra Pradesh, India
+91-XXXXXXXXXX
U73100AP2020OPC116488
116488
19 Nov 2020
-
-
Unlisted
Roc Vijayawada
Name | Designation | Appointment Date | Status |
---|---|---|---|
Telugu Narasaraju ![]() | Director | 19-Nov-2020 | Current |
Enhance accessibility to Vivi - Biologics (Opc)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Vivi - Biologics (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Telugu Narasaraju is a mutual person
There are no open charges registered against the company as per our records.
Vivi - Biologics (Opc) has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Vivi - Biologics (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vivi - Biologics (Opc)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Telugu Akula Narasaraju was appointed as a Director was appointed as a Director on 19 Nov 2020 & has been associated with this company since 4 years 3 months .
Vivi - Biologics (Opc) Private Limited was registered on 19 Nov 2020 with Roc Vijayawada & aged 4 years 3 months as per MCA records.
Vivi - Biologics (Opc) Private Limited was incorporated on 19 Nov 2020.
The authorized share capital of Vivi - Biologics (Opc) Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.
Currently 1 director is associated with Vivi - Biologics (Opc) Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Vivi - Biologics (Opc) Private Limited is 1/1536 Gandhi Nagar, Yemmiganur India, Kurnool, Andhra Pradesh, 518360.
The corporate identification number (CIN) of Vivi - Biologics (Opc) Private Limited is U73100AP2020OPC116488 and the company number is 116488 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.